click below
click below
Normal Size Small Size show me how
Movement-disorders
UVa med pharmacology block 3
| Question | Answer |
|---|---|
| Benztropine | Anticholinergic - tx early PD blocks muscarinic receptors and effects of increased AcH, also blocks dopamine reuptake - does not address major effects of dopamine deficiency many side effects including memory deficits limit use |
| Trihexyphenidyl | Anticholinergic - tx early PD blocks muscarinic receptors and effects of increased AcH, also blocks dopamine reuptake - does not address major effects of dopamine deficiency many side effects including memory deficits limit use |
| Amantadine | NMDA receptor blocker - tx early PD, suppresses drug induced dyskinesias mechanism not well established, unsure if clinically achieved levels actually block receptors Well tolerated but can cause confusion in elderly |
| Selegiline | selective MAO-B inhibitor (avoids tyramine effect) - PD tx - used concurrently w/L-Dopa in px w/declining response to L-Dopa metabolized to methamphetamine - causes side fx |
| Rasagiline (Azilect) | irreversible MAO-B inhibitor - early and late (w/L-Dopa) PD tx - enhances dopamine levels not metabolized to meth, well tolerated @ 1mg/day no tyramine effect and only rare serotonin syndrome |
| What is the proposed mechanism of MAO-I's in treating PD | they decrease catabolism of L-Dopa derived dopamine and increase dopamine levels in brain reduce oxidative deamination of dopamine produces toxic free radicals prevents PD from MPTP poisoning (MPTP oxidized by MAO-B, harms mitochondria) |
| What is myclonus and what is the usual etiology? | - Myclonus is "one or a series of shock-like contractions of a group of muscles" (stedman's dictionary) - Typically has a medical cause and should be treated ("usually due to a nervous system lesion" according to stedman's) |
| What is the primary principle of therapy in Parkinson's? how effective are drugs reaching this ideal? | - PRIMARY PRINCIPLE: augment nigrostriatal dopamine activity, ideally with constant receptor occupancy - ALL drugs fall short of this ideal, and ultimately ALL drugs fail for patients |
| Loss of which intrinsic projections is seen is Huntington's Disease? | Loss of instrinsic striatal projection neurons (D2>D1) |
| T or F: Tardive dyskinesia appears late in the course of treatment | FALSE It appears early (see powerpoint) |
| What histopathological finding is present year before parkinson's symptoms appear? | alpha-synuclein protein threads |
| What is spasticity and what is the cause of it? | - "One type of increase in muscle tone at rest; characterized by increased resistance to passive stretch, velocity dependent" (stedman's) - Due to loss of UMN innervation |
| How is the diagnosis of Prakinson's made? What confirmatory tests are available from the lab? What percentage of Dx are actually overlap syndromes? | - Entirely on clinical history and physical ***Four cardinal motor signs: - akinesia, bradykinesia, muscular rigidity, and tremor at rest - There are no confirmatory tests - Up to 25% of Dx are actually overlap syndromes |
| What two oral dopamine agnoists have a long duration of monotherapy? | pramipexole, ropinirole |
| Tardive dyskinesia is a possible side effect of what type of drug? What subtype has a lesser frequency? | - Side effect of neuroleptic therapy (first generation anti-psychotics) - "Atypical" anti-psychotics have amuch lesser frequency ** Rarely, if ever, seen with clozapine |
| Parkinson's Diease is a risk factor for what three conditions? | - depression (up to 40%) - dementina (at least half) - sleep disturbances (almost all) |
| What are anticholinergics used for? | tremor |
| What is Rotigotine? What receptors does in affect and at wha potency? When is it effective? | - Transdermal, 24 hr patch - D3>D2>D1 - early and later manifestations of AD |
| What accounts for the accompanying memory loss and depression in Parkinsons? | There are cortical changes that occur with substantia nigra changes |
| What is amantadine used for? | dykinesias, freezing |
| What is dystonia? When are they painful? | - sustained muscle contractions that may be: rythmic or static focal or generalized hereditary or drug induced or idiopathic - painful when agonists and antagonist contract at the same time |
| What oral dopamine agonist is both an anti-depressant and is neuroprotective? | Pramipexole |
| What is BEST to treat early Parkinsons? When do you avoid these drugs? | dopamine agonist over L-DOPA for most patients **avoid if frail elderly, demented, hypotensive |
| What is the overall effect of COMT inhibitors? Name the two for this lecture? | - increase bioavailability of dopmaine - tolcapone, entacapone |
| What is apomorphine? what receptors does it affect and at what frequency? what is it's approved use? side effects? | - Directly acting dopamine agonist - D2>D1 - approved for treating acute bradykinesia - nausea, hypotension |
| At what percentage of DA nigral neuron loss do you see symptoms? motor fluctuations? dementia? What percentage of DA neurons are lost per year is PD? | - Symptoms at 50 - 75% - Motor fluctuations at 90% - Dementia at over 90% -10% lost per year |
| What are advantages/disadvantage of oral dopamine agonists and when are they most effective? | - Advantages: long half-life, low risk of motor complication, low duration of monotherapy - Disadvantages: high risk of mental side-effects - MOST EFFECTIVE for early Parkinsons |
| Apomorphine | dopamine agonist D2>D1 - early PD tx "acute off periods", suuplement to oral therapy - first approved dopa ag high first pass metabolism - given paranterally, sublingually, or rectally |
| Pramipexole | Dopamine agonist highly selective for D2 - used alone in early PD tx, combination w/L-Dopa in late PD long T 1/2 (8-12hrs) given bid/tid |
| Ropinirole | Dopamine agonist highly selective for D2 - used alone in early PD tx, combination w/L-Dopa in late PD long T 1/2 (8-12hrs) given bid/tid |
| What are the side effects of dopamine agonist treatment | nausea, orthostatic hypotension (start @ low doses and titrate up to avoid), somnolence, constipation, peripheral edema, confusion/hallucination (esp in elderly and demented) Compulsive behaviors may limit tolerability |
| Levodopa (L-Dopa) | pro-dopamine, converted to dopamine in the brain, interacts w/both D1 & D2 receptors late PD tx short T 1/2 (90 mins) prolonged w/carbidopa tx or COMT inhib (up to 20hrs) many side fx |
| Levodopa/Carbidopa (Sinemet) | Same as L-Dopa but with longer T 1/2 - carbidopa inhibits DOPA decarboxylase |
| Entacapone | COMT inhibitor - reversible short acting - increase bioavailability of L-Dopa - does not cross BBB, acts peripherally - improves "on" time for PD px's while lowering L-Dopa intake taken w/L-dopa dose |
| What are the side effects of entacapone | major side effects relate to increased L-Dopa actions - dyskinesias, psychosis Also - diarrhea and discoloration of urine no hepatic necrosis like tolcapone |
| risperidone/olanzapine | atypical D2 antagonists - most effective class of agents for tx of chorea lower side effect profile makes atypicals better than 1st gen neuroleptics |
| tetrabenazine | selective VMAT-2 antagonist (ATP dependent pump that accumulates DA into vesicles) - reduces amount of DA released into cleft must be titrated per px, dose influenced by expressoin of CYP2D6 gene |
| what are the side effects of tetrabenazine? | Drug-induced parkinsonism and depression |
| Type A or B botulinum toxin | from clostridium botulinum - used for disabiling focal dystonias - toxin inhibits ACh release from cholinergic nerve endings causes temporary atrophy of associated nerves and fibers - not permanent req tx @ 3-6 month intervals |
| haloperidol/pimozide | atypical D2 antagonists - used for tx of severe Tics w/moderate to substantial efficacy serious side fx profile limits use to serious tics |